An independent intelligence board aggregating credible research, preprints, clinical findings, biohacking experiments, and community discussions on therapeutic peptides, longevity science, and evidence-based anti-aging. Stories are scored for relevance, credibility, novelty, momentum, and practicality so the most important findings surface first.
Someone on a public forum is asking whether the $29 online telehealth visit run by CVS can get them a prescription for a GLP-1 weight-loss drug tomorrow. They say they’re on Medi‑Cal (which in California doesn’t cover these weight-loss medicines), so they would pay cash. They’re a man with a BMI of 27.5 and recent blood pressure about 131/81, and they wonder if that meets the program’s criteria. They’re also curious whether anyone has used the service. GLP-1 drugs (like semaglutide, known commercially as Ozempic or Wegovy, and similar medicines) are laboratory-made versions that act like a natural gut hormone called GLP-1. That hormone helps control appetite, slows how fast the stomach empties, and influences blood-sugar control. Doctors prescribe GLP-1 medications for type 2 diabetes and, at higher doses, for chronic weight management. They are injected, usually once a week, and tend to reduce hunger and help people eat less. The snippet you shared isn’t a scientific study; it’s someone asking about a telehealth clinic and whether they meet the eligibility rules. What matters here is the clinic’s own criteria, not a new research finding. Many telehealth services and clinics that prescribe GLP-1s require a minimum body-mass index (BMI) threshold—often BMI ≥30 for weight loss alone, or BMI ≥27 if you also have an obesity-related condition like high blood pressure or high cholesterol. This person’s BMI of 27.5 plus a blood pressure of 131/81 might meet a “BMI ≥27 plus comorbidity” rule on paper, but services differ on how recent or documented the comorbidity has to be. One-off forum posts can’t confirm how CVS’s specific telehealth program will apply those rules. Why this matters: GLP-1 drugs are effective for many people at reducing weight and improving blood sugar, and there’s growing demand. For someone paying cash because their insurance won’t cover the drug, a quick online visit that leads to a prescription could save time and make access easier. People with a BMI in the high‑20s who also have documented high blood pressure or high cholesterol are exactly the group many prescribers consider when insurance criteria allow reduced thresholds. But the clinic will usually want recent, documented proof of that comorbidity—labs or vitals from a doctor’s visit—not just a memory of last year’s numbers. Caveats and risks: telehealth clinics vary in what documentation they accept and how thorough their check is. GLP-1 drugs have side effects—nausea, diarrhea, constipation, and sometimes more serious but rare problems—and they require medical follow-up. They’re prescription medicines, so a qualified prescriber should review your full medical history and current medications. Also, if your public insurance doesn’t cover the drug, paying out of pocket can be expensive. Finally, online services may refuse to prescribe if records are incomplete or if they think in-person evaluation is needed. Bottom line: You might qualify for a prescription through an online CVS telehealth visit if their rules accept a BMI ≥27 plus a documented comorbidity, but outcome depends on what proof they require and the clinician’s judgment. If you want the best chance, have recent blood pressure readings or lab results ready and be prepared that they may ask for an in‑person visit or decline if documentation is outdated.
Source: r/Semaglutide